Loading
Life sciences · Journal article
Frontiers in Biomaterials Science · November 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The importance of mechanotransduction as a key regulator of immune-cell function has grown, linking the tissue microenvironment to cell phenotype, activity, and response to therapy. Mechanobiology and stimuli-responsive biomaterials are converging to become a new approach to precision immunomodulation, the focus of this review. The roles of matrix stiffness, viscoelasticity, confinement, and nanoscale topography in sensing by integrins, focal-adhesion complexes, Piezo1, YAP/TAZ and nuclear mechanotransduction by LINC complexes, and their influence on cytoskeletal organization, transcriptional programs, and immune-cell function, are described. We then explore how macrophages, dendritic cells, T cells, neutrophils, monocytes, and regulatory immune cells combine these mechanical signals with biochemical signaling. We focus on stiffness-tunable, stress-relaxing, adaptive, self-healing, and architecture biomaterials, as well as magnetic, electrical, photonic, acoustic, and multi-stimuli-responsive platforms. They are evaluated for therapeutic roles in cancer immunotherapy, chronic inflammation, wound healing, fibrosis, infection and foreign body-associated responses. Lastly, we discuss barriers to translation, including biological heterogeneity, dosimetry, biosafety, manufacturing, and regulatory challenges, as well as new opportunities based on artificial intelligence, digital twins, real-time sensing, and closed-loop control. Together, these advances establish biomaterials as programmable interfaces that can dynamically integrate mechanical and biochemical cues to orchestrate and achieve a spatio-temporally precise immune regulation.